Founder | Multi-Omic Biomarkers | Translational Science | Clinical Diagnostics R&D| Metabolic and Systemic Health
Only 4 weeks left until IMSC2024! Excited to unveil #ProSeekBio's groundbreaking clinical mass spec assay pipeline for serum glycoform biomarker panels, beginning with an #ovarian cancer diagnostic blood test. Early detection is crucial for ovarian cancer, which has a high survival rate when treated at early stages. However, outdated tests lead to delayed diagnoses, with most cases detected at advanced stages after prolonged vague symptoms. #ProSeekBio is dedicated to enhancing women's health by collaborating with key stakeholders to create innovative clinical tests addressing unmet diagnostic needs. Stay tuned for more updates! #masspec #ovariancancer #Innovation